Can Diclofenac Be Used for Back Pain?

Oral diclofenac is one of the most commonly used painkillers for acute low back pain, and clinical evidence supports its use for short-term relief. Multiple guidelines list it alongside ibuprofen and naproxen as a first-line option when over-the-counter analgesics are appropriate. The story gets more complicated, though, when you look at specific formulations, certain types of back pain, and the cardiovascular risks that come with this particular drug.

What the Trial Evidence Shows for Acute Back Pain

A Cochrane review pooling 65 trials concluded that NSAIDs, as a class, are effective for short-term symptom relief in patients with acute and chronic low back pain without sciatica.¹ Diclofenac fits squarely in that category. In a controlled trial comparing low-dose diclofenac-K (12.5 mg) with ibuprofen (200 mg) and placebo for acute low back pain, diclofenac beat placebo on almost all pain and function measures, including pain intensity scores, global efficacy ratings, and a standardized back-function questionnaire.²

A separate Cochrane review focused specifically on acute low back pain found moderate-quality evidence that NSAIDs slightly outperform placebo for pain reduction and high-quality evidence for a small improvement in disability scores, though the reviewers noted the size of these effects is small and “probably not clinically relevant.”³ That phrasing can sound discouraging, but it reflects how pain researchers evaluate statistical averages across large groups. For individual patients, the benefit can feel meaningful, especially in the first few days of a flare-up.

An emergency-department trial that directly compared oral ibuprofen, ketorolac (a strong injectable NSAID), and diclofenac for acute nonradicular low back pain found no significant difference among the three drugs. By day five, roughly 71% of diclofenac patients reported mild or no pain, compared with 80% for ketorolac and 62% for ibuprofen.⁴ The takeaway: diclofenac works about as well as the other common NSAIDs for this kind of pain, and none of them blow the others out of the water.

How Diclofenac Reduces Pain

Diclofenac works the same way other NSAIDs do, by blocking enzymes called cyclooxygenase-1 and cyclooxygenase-2 (COX-1 and COX-2) with roughly equal potency.⁵ These enzymes produce prostaglandins, which are chemicals your body releases at the site of injury or inflammation. Prostaglandins sensitize nerve endings and promote swelling, so tamping them down reduces both pain and the inflammatory process. This is why diclofenac helps with the muscular and ligamentous inflammation typical of a low-back flare but does less for pain driven by nerve compression, as discussed below.

Where Diclofenac Does Not Work Well

If your back pain shoots down your leg, that is usually sciatica, meaning a nerve root is being irritated or compressed. NSAIDs perform poorly here. A Cochrane review of trials on NSAIDs for sciatica found virtually no difference between NSAIDs and placebo for pain reduction, with the pooled result essentially zero once a short-duration outlier trial was excluded.⁶ The quality of that evidence was rated very low, but the consistent finding across trials is that anti-inflammatory drugs simply do not address the mechanical nerve compression that drives sciatica symptoms. If leg pain is your main problem, diclofenac is unlikely to help much.

There is also a question about whether diclofenac actually speeds your overall recovery from an acute back episode or just makes the waiting more comfortable. A randomized trial that added diclofenac (or spinal manipulation) to standard first-line care found that neither treatment appreciably reduced the number of days until recovery compared with placebo.⁷ That does not mean the drug is useless; feeling less pain while your back heals on its own timeline is a legitimate goal. But if you are hoping diclofenac will shorten a two-week episode to one week, the data do not support that expectation.

Topical Diclofenac Gel for Back Pain

Diclofenac is widely sold as a gel or patch, and for joint pain in the knee or hand, topical NSAIDs have solid evidence behind them. For back pain, the picture is different. A review of topical NSAID trials concluded that the current evidence does not support the use of topical NSAIDs for acute or chronic low back pain.⁸ The likely reason is anatomical: the muscles and structures causing low-back pain sit deeper below the skin than, say, a knee joint, making it harder for a topically applied drug to reach therapeutic concentrations at the right spot.

Pharmacokinetic studies confirm that topical diclofenac gel produces blood levels five to seventeen times lower than the same drug taken orally.⁹ There is some evidence that the drug can penetrate to deeper tissues and maintain sustained local levels for several hours,¹⁰ but whether those levels are high enough to matter in the lumbar spine is unresolved.

A 2024 emergency-department study put this to the test directly, randomizing acute low-back-pain patients to oral ibuprofen alone, topical diclofenac gel alone, or both. Two days later, the oral ibuprofen group improved more than the topical diclofenac group, and adding the gel on top of ibuprofen did not produce a clear additional benefit.¹¹ Adverse events were uncommon in all groups. The gel is not harmful, and some people feel localized relief from the rubbing and cooling effect, but the controlled evidence for back pain specifically is weak compared to oral NSAIDs.

An interesting wrinkle: a trial tested a combination gel containing diclofenac plus capsaicin (the compound that makes hot peppers burn) against diclofenac gel alone and placebo. The combination beat both placebo and diclofenac alone, but capsaicin alone actually produced the largest pain reduction.¹² That raises the possibility that, for some topical back-pain products, the warming or counter-irritant ingredient is doing more of the heavy lifting than the NSAID itself.

Cardiovascular Risk Sets Diclofenac Apart

This is where diclofenac diverges from its NSAID peers in a way that matters for your safety. All NSAIDs carry some cardiovascular risk, but diclofenac consistently shows up at the higher end. A large Danish cohort study found that starting diclofenac was associated with a roughly 50% higher rate of major cardiovascular events compared to not starting any NSAID, and about a 20% higher rate compared to starting ibuprofen or acetaminophen.¹³ That elevated risk showed up even at low doses and across individual event types: heart attack, stroke, heart failure, atrial fibrillation, and cardiac death.

A separate series of emulated trials using Danish registry data compared diclofenac to other COX-2-selective NSAIDs (meloxicam, etodolac, celecoxib, and etoricoxib). Diclofenac initiators had about a 20% increase in major adverse cardiovascular events compared with other older COX-2 inhibitors, driven largely by a higher rate of cardiac death. The risk was strongest in women and in people already at high cardiovascular baseline risk.¹⁴ Interestingly, the cardiovascular event rate with diclofenac was similar to that seen with celecoxib and etoricoxib, which are drugs specifically designed to be COX-2 selective. That tracks with diclofenac’s pharmacology: despite being marketed as a traditional NSAID, it behaves more like a COX-2 inhibitor in the body.

An update review noted that one large multi-country European study found diclofenac’s heart-attack risk was only slightly elevated compared to non-use and not clearly different from other NSAIDs, while the Danish data showed a more pronounced signal.¹⁵ The discrepancy likely reflects differences in study populations and how “non-use” comparators were defined. But the overall weight of evidence has been enough for several countries, including the UK, to move diclofenac behind the pharmacy counter or restrict its availability. If you have existing heart disease, high blood pressure, or multiple cardiovascular risk factors, diclofenac is not the best NSAID to reach for. Naproxen or ibuprofen at the lowest effective dose are generally considered safer choices for those individuals.

Gut and Liver Side Effects

Stomach and intestinal problems are the classic downside of NSAIDs, and diclofenac is no exception. In guidelines and meta-analyses, diclofenac’s gastrointestinal profile sits in the middle of the NSAID pack: lower risk of major upper GI events than naproxen or ibuprofen, but higher than etoricoxib.¹⁶ Common complaints include stomach pain, nausea, and diarrhea, especially at higher doses or with prolonged use.

Topical diclofenac dramatically reduces these gut side effects. A head-to-head study of topical versus oral diclofenac in osteoarthritis patients found that total gastrointestinal events dropped from 48% with the oral form to 35% with the topical form, with particularly large reductions in abdominal pain, diarrhea, dyspepsia, and flatulence.¹⁷ That study was in knee osteoarthritis, not back pain specifically, but the safety profile of topical diclofenac is relevant if a clinician suggests it as a gentler alternative for someone with a sensitive stomach.

Diclofenac also has a specific reputation for liver enzyme elevations. In a large analysis of over 17,000 arthritis patients taking oral diclofenac for an average of 18 months, about 3% developed significantly elevated liver enzymes, with most elevations occurring in the first four to six months. Serious outcomes were rare: four liver-related hospitalizations, and no cases of liver failure, death, or transplant.¹⁸ The practical implication is that your doctor may want to check liver function with a blood test if you take oral diclofenac for more than a few weeks. For short courses to manage an acute back flare, this is rarely an issue. Even topical diclofenac has triggered isolated case reports of liver injury, though these are exceedingly uncommon.¹⁹

Using Diclofenac for Back Pain If You Are Older

Back pain becomes more common with age, and so do the conditions that make NSAIDs riskier: reduced kidney function, cardiovascular disease, and the need for multiple medications. A review of spine-pain pharmacotherapy in older adults found strong evidence supporting NSAID use, but with adjustments for gastrointestinal and renal risk factors, and with a recommendation to use the lowest therapeutic dose possible.²⁰ That is not a blanket prohibition. It means a 70-year-old with normal kidney function and no heart disease can still use diclofenac short-term, but a 70-year-old taking a blood thinner and a blood pressure medication needs closer monitoring or a different approach.

One reassuring finding comes from a long-term study of topical diclofenac gel in osteoarthritis patients: adverse event rates were nearly identical in patients under 65 and over 65. Patients with hypertension, type 2 diabetes, or cardiovascular disease also had similar rates to those without.¹⁷ Topical application is often the preferred route in older adults precisely because it minimizes systemic exposure and the downstream organ risks.

Combining Diclofenac with Other Treatments

Because no single drug resolves back pain completely, clinicians sometimes combine diclofenac with other agents. One combination that has drawn research interest is diclofenac plus thiocolchicoside, a muscle relaxant used in some countries. A systematic review of seven randomized trials found that the combination produced significant pain reduction and functional improvement compared to placebo or single-drug controls, with adverse events limited mainly to gastrointestinal discomfort and drowsiness.²¹ Thiocolchicoside is not available in the United States, so this particular combination is more relevant in European and Asian markets, but the principle of pairing an anti-inflammatory with a muscle relaxant for back pain is common everywhere.

One combination that did not pan out well in a controlled trial was adding topical diclofenac gel to oral ibuprofen for acute low back pain. As described earlier, the 2024 emergency-department study found that patients taking oral ibuprofen plus topical diclofenac did not improve more than those on ibuprofen alone.¹¹ Layering two NSAIDs, one oral and one topical, is also generally discouraged because it increases cumulative COX inhibition without proven additional benefit, while raising the ceiling for side effects.

Where Diclofenac Fits Among Your Options

Guidelines across multiple countries list oral NSAIDs alongside acetaminophen as first-line over-the-counter options for common pain conditions.²² Within the NSAID class, a large network meta-analysis of arthritis patients found that diclofenac at its higher dose (150 mg/day) was likely more effective for pain relief than celecoxib, naproxen, and ibuprofen, while its lower dose (100 mg/day) was comparable to all of them.¹⁶ That meta-analysis was in osteoarthritis and rheumatoid arthritis rather than back pain specifically, but it gives a useful sense of relative potency. Diclofenac is, milligram for milligram, one of the more potent commonly available NSAIDs.

Whether that extra potency matters enough to justify the cardiovascular signal is the real question. For someone with no heart-related risk factors who needs a few days of relief from an acute back episode, diclofenac is a reasonable choice. For someone who needs repeated or prolonged courses, or who has cardiovascular risk factors, the evidence tilts toward ibuprofen or naproxen as the safer bet, accepting a small potential trade-off in raw analgesic power. Topical diclofenac is the gentlest option in terms of systemic side effects, but its evidence base for back pain remains thin, making it something of a compromise: safer but possibly less effective for the specific problem you are trying to solve.